The ‘G’ kindred is remarkable for the high incidence of a specific cancer aggregate in its members, particularly adenocarcinoma of the colon and endometrium, with relatively early ages of onset and a remarkably high incidence of multiple primaries. This specific familial association has previously been detailed in the literature as the ‘cancer family syndrome’. The parent-child concordance, observed between cancer-affected parents in the kindred and their 219 offspring, is 36.5%. The sibling-pair concordance for cancer, between first-affected siblings and their brothers and sisters, is 36.6% of 153 pairs. Manifestation of the familial malignancy in this particular kindred does not show sex influence, sex limitation, or disparity between matriarchal and patriarchal association for the cancer diathesis. The data are consistent with the hypothesis that the familial diathesis for the defined aggregate, in the ‘G’ kindred, is transmitted according to the mode of an autosomal domiant gene with an observed penetrance of about 73%.

Keywords:
Cancer genetics, Cancer Family Syndrome, Cancer Family ‘G’, High Cancer Risk Family
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.